Abvc Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.74

+0.14 (+8.75%)

As of Feb 8, 2:19 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,319.5% upside

Low Target $17.28

Average Target $24.70

High Target $43.03

Current Price $1.74

Current
$1.74

Target
$24.70

$17.28 $24.70 avg $43.03

Scenario Analysis

Bear Case

$17.28

893.1%

Low target

Base Case

$24.70

+1,319.5%

Avg target

Bull Case

$43.03

+2,373.0%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$26.04

-93.3% from high

52-Week Low

$14.90

+-88.3% from low

Target vs 52W High

$24.70

-5.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%